Drug Discovery in the Age of Big Data – The Impact of RNAi & CRISPR/Cas9 Technologies
Posted in Archive
| Tagged AI / data analytics / healthtech / informatics, Analysis, Animal models, Assay development optimisation & technology, Business, Cell / tissue culture, Cell culture, Cell therapy, Cellular assays, Clinical trials, Drug development, Drug discovery, Drug targets, Enabling technologies, Gene editing, Gene therapy, Genetics / genomes, Genomics, High Content Screening, High throughput screening, Lead discovery, Molecular medicine, Precision medicine, Preclinical, Protein chemistry / Proteomics, RNA, Screening, Sequencing, Stem cells, Target validation, Toxicology
